{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T20:19:55Z","timestamp":1788034795651,"version":"build-2784847793"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T00:00:00Z","timestamp":1667001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T00:00:00Z","timestamp":1667001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>Observational studies have demonstrated associations between gout and hypertension, but whether they are causal remains unclear. Our work aims to assess the causal relationship between gout and hypertension.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We obtained genetic information from the Taiwan Biobank, including 88,347 participants and 686,439 single-nucleotide polymorphisms (SNPs). A novel model of Mendelian randomisation (MR) with coarsened exposures was used to examine the causality between the liability of gout on hypertension and vice versa, using 4 SNPs associated with gout and 10 SNPs associated with hypertension after removal of SNPs associated with measured confounders. The binary exposure (gout\/hypertension) can be considered a coarsened approximation of a latent continuous trait. The inverse-variance weighted (IVW) and polygenic risk score (PRS) methods were used to estimate effect size. The MR analysis with coarsened exposures was performed with and without adjustments for covariates.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of the 88,347 participants, 3253 (3.68%) had gout and 11,948 (13.52%) had hypertension (men, 31.9%; mean age 51.1 [SD, 11.1] years). After adjusting to measured confounders, MR analysis with coarsened exposures showed a significant positive causal effect of the liability of gout on hypertension in both the IVW method (relative risk [RR], 1.10; 95% confidence interval [CI], 1.03\u20131.19; <jats:italic>p<\/jats:italic>\u2009=\u20090.0077) and the PRS method (RR, 1.10; 95% CI, 1.02\u20131.19; <jats:italic>p<\/jats:italic>\u2009=\u20090.0092). The result of causality was the same before and after involving measured confounders. However, there was no causal effect of the liability of hypertension on gout.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In this study, we showed that the liability of gout has a causal effect on hypertension, but the liability of hypertension does not have a causal effect on gout. Adequate management of gout may reduce the risk of developing hypertension.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13075-022-02933-4","type":"journal-article","created":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T06:03:18Z","timestamp":1667023398000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Assessing the causal relationships between gout and hypertension: a bidirectional Mendelian randomisation study with coarsened exposures"],"prefix":"10.1186","volume":"24","author":[{"given":"Benjamin","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huang-Ping","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Jing","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang-Chin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Che-Kai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiya","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Doherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shang-Hung","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Te","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuang-Hui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Fu","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,29]]},"reference":[{"key":"2933_CR1","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1136\/annrheumdis-2014-206410","volume":"75","author":"CF Kuo","year":"2016","unstructured":"Kuo CF, Grainge MJ, Mallen C, Zhang W, Doherty M. Comorbidities in patients with gout prior to and following diagnosis: case-control study. Ann Rheum Dis. 2016;75:210\u20137.","journal-title":"Ann Rheum Dis"},{"key":"2933_CR2","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1161\/HYPERTENSIONAHA.116.08998","volume":"69","author":"M Kuwabara","year":"2017","unstructured":"Kuwabara M, Niwa K, Hisatome I, Nakagawa T, Roncal-Jimenez CA, Andres-Hernando A, et al. Asymptomatic hyperuricemia without comorbidities predicts cardiometabolic diseases: five-year Japanese cohort study. Hypertension. 2017;69:1036\u201344.","journal-title":"Hypertension"},{"key":"2933_CR3","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1093\/rheumatology\/keaa773","volume":"60","author":"G Sandoval-Plata","year":"2021","unstructured":"Sandoval-Plata G, Nakafero G, Chakravorty M, Morgan K, Abhishek A. Association between serum urate, gout and comorbidities: a case-control study using data from the UK Biobank. Rheumatology (Oxford). 2021;60:3243\u201351.","journal-title":"Rheumatology (Oxford)"},{"key":"2933_CR4","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1161\/HYPERTENSIONAHA.118.11390","volume":"72","author":"H Tomiyama","year":"2018","unstructured":"Tomiyama H, Shiina K, Vlachopoulos C, Iwasaki Y, Matsumoto C, Kimura K, et al. Involvement of arterial stiffness and inflammation in hyperuricemia-related development of hypertension. Hypertension. 2018;72:739\u201345.","journal-title":"Hypertension"},{"key":"2933_CR5","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1001\/archinternmed.2008.521","volume":"169","author":"JP Forman","year":"2009","unstructured":"Forman JP, Choi H, Curhan GC. Uric acid and insulin sensitivity and risk of incident hypertension. Arch Intern Med. 2009;169:155\u201362.","journal-title":"Arch Intern Med"},{"key":"2933_CR6","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1111\/j.1523-1755.2004.00909.x","volume":"66","author":"TS Perlstein","year":"2004","unstructured":"Perlstein TS, Gumieniak O, Hopkins PN, Murphey LJ, Brown NJ, Williams GH, et al. Uric acid and the state of the intrarenal renin-angiotensin system in humans. Kidney Int. 2004;66:1465\u201370.","journal-title":"Kidney Int"},{"key":"2933_CR7","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1093\/rheumatology\/keq184","volume":"49","author":"WJ Ho","year":"2010","unstructured":"Ho WJ, Tsai WP, Yu KH, Tsay PK, Wang CL, Hsu TS, et al. Association between endothelial dysfunction and hyperuricaemia. Rheumatology (Oxford). 2010;49:1929\u201334.","journal-title":"Rheumatology (Oxford)"},{"key":"2933_CR8","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1016\/S0140-6736(16)00346-9","volume":"388","author":"N Dalbeth","year":"2016","unstructured":"Dalbeth N, Merriman TR, Stamp LK. Gout Lancet. 2016;388:2039\u201352.","journal-title":"Gout Lancet"},{"key":"2933_CR9","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1001\/jama.300.8.924","volume":"300","author":"DI Feig","year":"2008","unstructured":"Feig DI, Soletsky B, Johnson RJ. Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial. JAMA. 2008;300:924\u201332.","journal-title":"JAMA"},{"key":"2933_CR10","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.3346\/jkms.2014.29.8.1077","volume":"29","author":"HA Kim","year":"2014","unstructured":"Kim HA, Seo YI, Song YW. Four-week effects of allopurinol and febuxostat treatments on blood pressure and serum creatinine level in gouty men. J Korean Med Sci. 2014;29:1077\u201381.","journal-title":"J Korean Med Sci"},{"key":"2933_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ije\/dyg070","volume":"32","author":"GD Smith","year":"2003","unstructured":"Smith GD, Ebrahim S. \u201cMendelian randomization\u201d: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol. 2003;32:1\u201322.","journal-title":"Int J Epidemiol"},{"key":"2933_CR12","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1177\/0962280206077743","volume":"16","author":"V Didelez","year":"2007","unstructured":"Didelez V, Sheehan N. Mendelian randomization as an instrumental variable approach to causal inference. Stat Methods Med Res. 2007;16:309\u201330.","journal-title":"Stat Methods Med Res"},{"key":"2933_CR13","doi-asserted-by":"publisher","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","volume":"23","author":"G Davey Smith","year":"2014","unstructured":"Davey Smith G, Hemani G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum Mol Genet. 2014;23:R89-98.","journal-title":"Hum Mol Genet"},{"key":"2933_CR14","doi-asserted-by":"publisher","first-page":"e2034461","DOI":"10.1001\/jamanetworkopen.2020.34461","volume":"4","author":"MG Levin","year":"2021","unstructured":"Levin MG, Klarin D, Assimes TL, Freiberg MS, Ingelsson E, Lynch J, et al. Genetics of smoking and risk of atherosclerotic cardiovascular diseases: a Mendelian randomization study. JAMA Netw Open. 2021;4:e2034461.","journal-title":"JAMA Netw Open"},{"key":"2933_CR15","doi-asserted-by":"publisher","first-page":"e1003410","DOI":"10.1371\/journal.pmed.1003410","volume":"17","author":"DB Rosoff","year":"2020","unstructured":"Rosoff DB, Davey Smith G, Mehta N, Clarke TK, Lohoff FW. Evaluating the relationship between alcohol consumption, tobacco use, and cardiovascular disease: a multivariable Mendelian randomization study. PLoS Med. 2020;17:e1003410.","journal-title":"PLoS Med"},{"key":"2933_CR16","doi-asserted-by":"publisher","first-page":"e1002937","DOI":"10.1371\/journal.pmed.1002937","volume":"16","author":"X Li","year":"2019","unstructured":"Li X, Meng X, He Y, Spiliopoulou A, Timofeeva M, Wei WQ, et al. Genetically determined serum urate levels and cardiovascular and other diseases in UK Biobank cohort: a phenome-wide mendelian randomization study. PLoS Med. 2019;16:e1002937.","journal-title":"PLoS Med"},{"key":"2933_CR17","doi-asserted-by":"publisher","first-page":"f4262","DOI":"10.1136\/bmj.f4262","volume":"347","author":"TM Palmer","year":"2013","unstructured":"Palmer TM, Nordestgaard BG, Benn M, Tybjaerg-Hansen A, Davey Smith G, Lawlor DA, et al. Association of plasma uric acid with ischaemic heart disease and blood pressure: mendelian randomisation analysis of two large cohorts. BMJ. 2013;347:f4262.","journal-title":"BMJ"},{"key":"2933_CR18","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1136\/annrheumdis-2017-212534","volume":"77","author":"X Li","year":"2018","unstructured":"Li X, Meng X, Spiliopoulou A, Timofeeva M, Wei WQ, Gifford A, et al. MR-PheWAS: exploring the causal effect of SUA level on multiple disease outcomes by using genetic instruments in UK Biobank. Ann Rheum Dis. 2018;77:1039\u201347.","journal-title":"Ann Rheum Dis"},{"key":"2933_CR19","doi-asserted-by":"publisher","first-page":"e012738","DOI":"10.1161\/JAHA.119.012738","volume":"8","author":"A Efstathiadou","year":"2019","unstructured":"Efstathiadou A, Gill D, McGrane F, Quinn T, Dawson J. Genetically determined uric acid and the risk of cardiovascular and neurovascular diseases: a Mendelian randomization study of outcomes investigated in randomized trials. J Am Heart Assoc. 2019;8:e012738.","journal-title":"J Am Heart Assoc"},{"key":"2933_CR20","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1002\/gepi.22376","volume":"45","author":"MJ Tudball","year":"2021","unstructured":"Tudball MJ, Bowden J, Hughes RA, Ly A, Munafo MR, Tilling K, et al. Mendelian randomisation with coarsened exposures. Genet Epidemiol. 2021;45:338\u201350.","journal-title":"Genet Epidemiol"},{"key":"2933_CR21","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2217\/14622416.9.2.235","volume":"9","author":"CT Fan","year":"2008","unstructured":"Fan CT, Lin JC, Lee CH. Taiwan Biobank: a project aiming to aid Taiwan\u2019s transition into a biomedical island. Pharmacogenomics. 2008;9:235\u201346.","journal-title":"Pharmacogenomics"},{"key":"2933_CR22","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/nrrheum.2015.91","volume":"11","author":"CF Kuo","year":"2015","unstructured":"Kuo CF, Grainge MJ, Zhang W, Doherty M. Global epidemiology of gout: prevalence, incidence and risk factors. Nat Rev Rheumatol. 2015;11:649\u201362.","journal-title":"Nat Rev Rheumatol"},{"key":"2933_CR23","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13742-015-0047-8","volume":"4","author":"CC Chang","year":"2015","unstructured":"Chang CC, Chow CC, Tellier LC, Vattikuti S, Purcell SM, Lee JJ. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience. 2015;4:7.","journal-title":"Gigascience"},{"key":"2933_CR24","doi-asserted-by":"crossref","unstructured":"Myers TA, Chanock SJ, Machiela MJ. LDlinkR: An R package for rapidly calculating linkage disequilibrium statistics in diverse populations. Front Genet. 2020;11:157.","DOI":"10.3389\/fgene.2020.00157"},{"key":"2933_CR25","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1093\/bioinformatics\/btw373","volume":"32","author":"JR Staley","year":"2016","unstructured":"Staley JR, Blackshaw J, Kamat MA, Ellis S, Surendran P, Sun BB, et al. PhenoScanner: a database of human genotype-phenotype associations. Bioinformatics. 2016;32:3207\u20139.","journal-title":"Bioinformatics"},{"key":"2933_CR26","doi-asserted-by":"publisher","first-page":"4851","DOI":"10.1093\/bioinformatics\/btz469","volume":"35","author":"MA Kamat","year":"2019","unstructured":"Kamat MA, Blackshaw JA, Young R, Surendran P, Burgess S, Danesh J, et al. PhenoScanner V2: an expanded tool for searching human genotype-phenotype associations. Bioinformatics. 2019;35:4851\u20133.","journal-title":"Bioinformatics"},{"key":"2933_CR27","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1080\/01621459.2018.1434530","volume":"113","author":"SA Swanson","year":"2018","unstructured":"Swanson SA, Hernan MA, Miller M, Robins JM, Richardson TS. Partial identification of the average treatment effect using instrumental variables: review of methods for binary instruments, treatments, and outcomes. J Am Stat Assoc. 2018;113:933\u201347.","journal-title":"J Am Stat Assoc"},{"key":"2933_CR28","doi-asserted-by":"publisher","DOI":"10.1201\/b18084","volume-title":"Mendelian randomization : methods for using genetic variants in causal estimation","author":"S Burgess","year":"2015","unstructured":"Burgess S, Thompson SG. Mendelian randomization\u202f: methods for using genetic variants in causal estimation. Boca Raton: CRC Press, Taylor & Francis Group; 2015."},{"key":"2933_CR29","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/gepi.21758","volume":"37","author":"S Burgess","year":"2013","unstructured":"Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013;37:658\u201365.","journal-title":"Genet Epidemiol"},{"key":"2933_CR30","first-page":"2681","volume":"187","author":"J Bowden","year":"2018","unstructured":"Bowden J, Hemani G, Davey Smith G. Invited commentary: detecting individual and global horizontal pleiotropy in mendelian randomization-a job for the humble heterogeneity statistic? Am J Epidemiol. 2018;187:2681\u20135.","journal-title":"Am J Epidemiol"},{"key":"2933_CR31","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1093\/ije\/dyx034","volume":"46","author":"OO Yavorska","year":"2017","unstructured":"Yavorska OO, Burgess S. MendelianRandomization: an R package for performing Mendelian randomization analyses using summarized data. Int J Epidemiol. 2017;46:1734\u20139.","journal-title":"Int J Epidemiol"},{"key":"2933_CR32","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1198\/073500108000000024","volume":"26","author":"C Hansen","year":"2008","unstructured":"Hansen C, Hausman J, Newey W. Estimation with many instrumental variables. J Bus Econ Stat. 2008;26:398\u2013422.","journal-title":"J Bus Econ Stat"},{"key":"2933_CR33","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/ije\/dyr036","volume":"40","author":"S Burgess","year":"2011","unstructured":"Burgess S, Thompson SG, Collaboration CCG. Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol. 2011;40:755\u201364.","journal-title":"Int J Epidemiol"},{"key":"2933_CR34","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1093\/ije\/dyt093","volume":"42","author":"S Burgess","year":"2013","unstructured":"Burgess S, Thompson SG. Use of allele scores as instrumental variables for Mendelian randomization. Int J Epidemiol. 2013;42:1134\u201344.","journal-title":"Int J Epidemiol"},{"key":"2933_CR35","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1002\/sim.6835","volume":"35","author":"S Burgess","year":"2016","unstructured":"Burgess S, Dudbridge F, Thompson SG. Combining information on multiple instrumental variables in Mendelian randomization: comparison of allele score and summarized data methods. Stat Med. 2016;35:1880\u2013906.","journal-title":"Stat Med"},{"key":"2933_CR36","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1002\/gepi.21614","volume":"36","author":"SH Lee","year":"2012","unstructured":"Lee SH, Goddard ME, Wray NR, Visscher PM. A better coefficient of determination for genetic profile analysis. Genet Epidemiol. 2012;36:214\u201324.","journal-title":"Genet Epidemiol"},{"key":"2933_CR37","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s42003-019-0339-0","volume":"2","author":"M Nakatochi","year":"2019","unstructured":"Nakatochi M, Kanai M, Nakayama A, Hishida A, Kawamura Y, Ichihara S, et al. Genome-wide meta-analysis identifies multiple novel loci associated with serum uric acid levels in Japanese individuals. Commun Biol. 2019;2:115.","journal-title":"Commun Biol"},{"key":"2933_CR38","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1038\/s41588-018-0205-x","volume":"50","author":"E Evangelou","year":"2018","unstructured":"Evangelou E, Warren HR, Mosen-Ansorena D, Mifsud B, Pazoki R, Gao H, et al. Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits. Nat Genet. 2018;50:1412\u201325.","journal-title":"Nat Genet"},{"key":"2933_CR39","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1161\/01.HYP.0000249768.26560.66","volume":"48","author":"PB Mellen","year":"2006","unstructured":"Mellen PB, Bleyer AJ, Erlinger TP, Evans GW, Nieto FJ, Wagenknecht LE, et al. Serum uric acid predicts incident hypertension in a biethnic cohort: the atherosclerosis risk in communities study. Hypertension. 2006;48:1037\u201342.","journal-title":"Hypertension"},{"key":"2933_CR40","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1161\/01.HYP.0000248752.08807.4c","volume":"48","author":"TS Perlstein","year":"2006","unstructured":"Perlstein TS, Gumieniak O, Williams GH, Sparrow D, Vokonas PS, Gaziano M, et al. Uric acid and the development of hypertension: the normative aging study. Hypertension. 2006;48:1031\u20136.","journal-title":"Hypertension"},{"key":"2933_CR41","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/acr.20344","volume":"63","author":"PC Grayson","year":"2011","unstructured":"Grayson PC, Kim SY, LaValley M, Choi HK. Hyperuricemia and incident hypertension: a systematic review and meta-analysis. Arthritis Care Res (Hoboken). 2011;63:102\u201310.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2933_CR42","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1002\/art.1780180713","volume":"18","author":"SL Wallace","year":"1975","unstructured":"Wallace SL. Gout and hypertension. Arthritis Rheum. 1975;18:721\u20134.","journal-title":"Arthritis Rheum"},{"key":"2933_CR43","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0140-6736(66)90005-5","volume":"1","author":"A Breckenridge","year":"1966","unstructured":"Breckenridge A. Hypertension and hyperuricaemia. Lancet. 1966;1:15\u20138.","journal-title":"Lancet"},{"key":"2933_CR44","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/0002-9343(87)90441-4","volume":"82","author":"EW Campion","year":"1987","unstructured":"Campion EW, Glynn RJ, DeLabry LO. Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study. Am J Med. 1987;82:421\u20136.","journal-title":"Am J Med"},{"key":"2933_CR45","first-page":"1575","volume":"31","author":"AA Riedel","year":"2004","unstructured":"Riedel AA, Nelson M, Joseph-Ridge N, Wallace K, MacDonald P, Becker M. Compliance with allopurinol therapy among managed care enrollees with gout: a retrospective analysis of administrative claims. J Rheumatol. 2004;31:1575\u201381.","journal-title":"J Rheumatol"},{"key":"2933_CR46","doi-asserted-by":"publisher","first-page":"925","DOI":"10.4065\/81.7.925","volume":"81","author":"CA Sarawate","year":"2006","unstructured":"Sarawate CA, Brewer KK, Yang W, Patel PA, Schumacher HR, Saag KG, et al. Gout medication treatment patterns and adherence to standards of care from a managed care perspective. Mayo Clin Proc. 2006;81:925\u201334.","journal-title":"Mayo Clin Proc"},{"key":"2933_CR47","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/j.1751-7176.2012.00674.x","volume":"14","author":"MA McAdams-DeMarco","year":"2012","unstructured":"McAdams-DeMarco MA, Maynard JW, Baer AN, Coresh J. Hypertension and the risk of incident gout in a population-based study: the atherosclerosis risk in communities cohort. J Clin Hypertens (Greenwich). 2012;14:675\u20139.","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"2933_CR48","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3390\/biom11020280","volume":"11","author":"WZ Zhang","year":"2021","unstructured":"Zhang WZ. Why does hyperuricemia not necessarily induce gout? Biomolecules. 2021;11:280.","journal-title":"Biomolecules"},{"key":"2933_CR49","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/nrrheum.2014.124","volume":"10","author":"P Richette","year":"2014","unstructured":"Richette P, Perez-Ruiz F, Doherty M, Jansen TL, Nuki G, Pascual E, et al. Improving cardiovascular and renal outcomes in gout: what should we target? Nat Rev Rheumatol. 2014;10:654\u201361.","journal-title":"Nat Rev Rheumatol"},{"key":"2933_CR50","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/art.38203","volume":"66","author":"S Bruderer","year":"2014","unstructured":"Bruderer S, Bodmer M, Jick SS, Meier CR. Use of diuretics and risk of incident gout: a population-based case-control study. Arthritis Rheumatol. 2014;66:185\u201396.","journal-title":"Arthritis Rheumatol"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-022-02933-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-022-02933-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-022-02933-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T10:09:41Z","timestamp":1667124581000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-022-02933-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,29]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2933"],"URL":"https:\/\/doi.org\/10.1186\/s13075-022-02933-4","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,29]]},"assertion":[{"value":"24 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Review Board of Chang Gung Memorial Hospital (IRB201601870B0) and the Research Committee of the Taiwan Biobank. Patient consent to participate is not applicable as all participants joined the Taiwan Biobank on a voluntary basis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"243"}}